Vendor review
Kerui Peptide HongKong reviews
Kerui Peptide HongKong reviews from 38 independent lab tests (Retatrutide, Tirzepatide and NAD+): grade A, purity and fill accuracy. Is Kerui Peptide HongKong legit? See what its vials showed.
What the lab tests show
38 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 1, 2026 | BPC-157 | 5 mg | Fail | View | |
| Oct 1, 2026 | Tirzepatide | 99.9 % | 19.99 mg of 20 mg (0 %) | Pass | View |
| Oct 1, 2026 | TB-500 | 5 mg | Fail | View | |
| Sep 24, 2026 | TB-500 | 99.6 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| Sep 20, 2026 | Retatrutide | 99.58 % | 24.28 mg of 20 mg (21 %) | Pass | View |
| Sep 19, 2026 | GHK-Cu | 99.7 % | 54 mg of 50 mg (8 %) | Pass | View |
| Sep 18, 2026 | Retatrutide | 99.9 % | 29.5 mg of 30 mg (-2 %) | Pass | View |
| Sep 17, 2026 | GHK-Cu | 99.9 % | 54.7 mg of 50 mg (9 %) | Pass | View |
| Sep 17, 2026 | NAD+ | 98.4 % | 503 mg of 1000 mg (-50 %) | Pass | View |
| Sep 15, 2026 | GHK-Cu | 99.9 % | 89.4 mg of 100 mg (-11 %) | Pass | View |
| Sep 15, 2026 | Retatrutide | 99.9 % | 11.2 mg of 10 mg (12 %) | Pass | View |
| Sep 10, 2026 | Tirzepatide | 30 mg | Fail | View | |
| Aug 28, 2026 | Retatrutide | 10 mg | Fail | View | |
| Aug 26, 2026 | Retatrutide | 99.9 % | 18.4 mg of 20 mg (-8 %) | Pass | View |
| Aug 15, 2026 | Retatrutide | 99.7 % | 11.6 mg of 10 mg (16 %) | Pass | View |
| Aug 15, 2026 | Tesamorelin | 99.6 % | 11.9 mg of 10 mg (19 %) | Pass | View |
| Aug 13, 2026 | Retatrutide | 99.9 % | 31 mg of 30 mg (3 %) | Pass | View |
| Aug 5, 2026 | Tesamorelin | 99.9 % | 4.89 mg of 5 mg (-2 %) | Pass | View |
| Aug 5, 2026 | Tirzepatide | 99.9 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Aug 3, 2026 | BPC-157 | 99.9 % | 9.13 mg of 10 mg (-9 %) | Pass | View |
| Aug 3, 2026 | NAD+ | 93.1 % | 580 mg of 500 mg (16 %) | Pass | View |
| Aug 3, 2026 | Retatrutide | 99.9 % | 25.1 mg of 30 mg (-16 %) | Pass | View |
| Jul 22, 2026 | Tirzepatide | 99.9 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Jul 13, 2026 | NAD+ | 92.5 % | 583 mg of 500 mg (17 %) | Pass | View |
| Jul 10, 2026 | Retatrutide | 99.9 % | 22.2 mg of 20 mg (11 %) | Pass | View |
| Jun 17, 2026 | Tirzepatide | 99.8 % | 21 mg of 20 mg (5 %) | Pass | View |
| Jun 4, 2026 | Tesamorelin | 10 mg | Fail | View | |
| Jun 2, 2026 | Retatrutide | 10 mg | Fail | View | |
| May 28, 2026 | Retatrutide | 99.9 % | 5.05 mg of 5 mg (1 %) | Pass | View |
| May 20, 2026 | Retatrutide | 99.9 % | 42.5 mg of 60 mg (-29 %) | Pass | View |
| May 20, 2026 | Retatrutide | 85.9 % | 19.3 mg of 20 mg (-3 %) | Pass | View |
| May 20, 2026 | Retatrutide | 10 mg | Fail | View | |
| May 20, 2026 | Tirzepatide | 99.9 % | 57.7 mg of 60 mg (-4 %) | Pass | View |
| May 8, 2026 | BPC-157 | 99.7 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| May 8, 2026 | NAD+ | 99.6 % | 838 mg of 500 mg (68 %) | Pass | View |
| Feb 2, 2026 | GHK-Cu | 99.9 % | 48.9 mg of 50 mg (-2 %) | Pass | View |
| Jan 29, 2026 | Retatrutide | 99.46 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Jul 3, 2025 | Retatrutide | 99.52 % | 9.11 mg of 10 mg (-9 %) | Pass | View |
What Kerui Peptide HongKong sells
No current listings on record.
About Kerui Peptide HongKong
Finnrick has tested 38 samples from Kerui Peptide HongKong across 7 products.